Polyphenols reduce tumor markers for prostate cancer

A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study.

This randomized controlled double-blind study examined the effects of a polyphenol-rich nutritional supplement on prostate-specific antigen (PSA), an important tumor marker for prostate cancer. Towards this goal, over a period of 6 months, 199 prostate cancer patients with an average age of 74 years received either a capsule containing various micronutrients - pomegranate, green tea, broccoli and turmeric - or an ineffective placebo. The result of the study was a reduction of the PSA levels in the micronutrient group, thus suggesting a favorable effect of this dietary supplement on the course of prostate cancer. Further details can be found in the study.
Thomas R, Williams M, Sharma H, Chaudry A, Bellamy P. A double-blind, placebo-controlled randomised trial evaluating the effect of a polyphenol-rich whole food supplement on PSA progression in men with prostate cancer--the U.K. NCRN Pomi-T study. Prostate Cancer Prostatic Dis. 2014 Jun;17(2):180-6.



Leave a Reply